These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18447615)

  • 1. Antiretroviral therapy and central nervous system HIV type 1 infection.
    Price RW; Spudich S
    J Infect Dis; 2008 May; 197 Suppl 3(Suppl 3):S294-306. PubMed ID: 18447615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of HIV-1 drug resistance in the neurological compartment.
    Antinori A; Cingolani A; Giancola ML; Forbici F; De Luca A; Perno CF
    Scand J Infect Dis Suppl; 2003; 106():41-4. PubMed ID: 15000582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
    Valle M; Price RW; Nilsson A; Heyes M; Verotta D
    Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
    Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
    J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated neurological disorders: a guide to pharmacotherapy.
    Tan IL; McArthur JC
    CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
    Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
    Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
    Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
    BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
    Cinque P; Nebuloni M; Santovito ML; Price RW; Gisslen M; Hagberg L; Bestetti A; Vago G; Lazzarin A; Blasi F; Sidenius N
    Ann Neurol; 2004 May; 55(5):687-94. PubMed ID: 15122709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system.
    Price RW; Deeks SG
    J Neurovirol; 2004; 10 Suppl 1():44-51. PubMed ID: 14982739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy.
    Haas DW
    J Neurovirol; 2004; 10 Suppl 1():33-7. PubMed ID: 14982737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape.
    Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J
    Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain MRI Features of CSF Human Immunodeficiency Virus Escape.
    Narvid J; Callen A; Talbott J; Uzelac A; Dupont SM; Chow F; Price RW; Rehani B
    J Neuroimaging; 2018 Nov; 28(6):601-607. PubMed ID: 30079471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.
    Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert S; Riederer P; ter Meulen V; Sopper S;
    J Neurovirol; 2007 Jun; 13(3):225-32. PubMed ID: 17613712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV encephalitis in a patient on antiretroviral therapy: a case report.
    Hlebowicz M; Parczewski M; Jakubowski P
    Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of HIV infection from the neurologic viewpoint. Therapy must reach the brain].
    von Giesen HJ; Köller H; Arendt G
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():46-50. PubMed ID: 12043074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
    Strain MC; Letendre S; Pillai SK; Russell T; Ignacio CC; Günthard HF; Good B; Smith DM; Wolinsky SM; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman DD; Marcotte T; McCutchan JA; Ellis RJ; Wong JK
    J Virol; 2005 Feb; 79(3):1772-88. PubMed ID: 15650202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, dementia and antiretroviral drugs: 30 years of an epidemic.
    Manji H; Jäger HR; Winston A
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1126-37. PubMed ID: 23378642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.
    Mehling M; Drechsler H; Kuhle J; Hardmeier M; Doerries R; Ruegg S; Gass A
    J Neurovirol; 2008 Jan; 14(1):78-84. PubMed ID: 18300078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
    Aweeka F; Jayewardene A; Staprans S; Bellibas SE; Kearney B; Lizak P; Novakovic-Agopian T; Price RW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):39-43. PubMed ID: 9928728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.